Cargando…
Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479487/ https://www.ncbi.nlm.nih.gov/pubmed/32934756 http://dx.doi.org/10.1155/2020/8855423 |